Analysis of Diabetes Mellitus-Related Amputations in the State of Espírito Santo, Brazil
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Study Location and Period
2.3. Study Population and Eligibility Criteria
2.4. Data Collection
2.5. Data Analysis
2.6. Ethical and Legal Aspects of the Research
3. Results
Prevalence of DM-Related Amputations
4. Discussion
DM-Related Amputations
5. Conclusion
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- International Diabetes Federation. Diabetes Atlas, 8th ed.; International Diabetes Federation: Brussels, Belgium, 2017; Available online: http://diabetesatlas.org/resources/2017-atlas.html (accessed on 3 March 2019).
- Sociedade Brasileira de Diabetes. Diretrizes da Sociedade Brasileira de Diabetes 2017–2018; Sao Paulo, 2017. Available online: https://www.diabetes.org.br/profissionais/images/2017/diretrizes/diretrizes-sbd-2017–2018.pdf (accessed on 3 March 2019).
- Santos, M.A.; Oliveira, M.M.; Andrade, S.S.; Nunes, M.L.; Malta, D.C.; Moura, L.D. Tendências da morbidade hospitalar por doenças crônicas não transmissíveis no Brasil. Epidemiol. Serv. Saúde 2015, 24, 389–398. [Google Scholar] [CrossRef]
- Tavares, D.M.S.; Dias, F.A.; Araújo, L.R.; Pereira, G.A. Perfil de clientes submetidos a amputações relacionadas ao diabetes mellitus. Rev. Bras. Enferm. 2009, 62, 825–830. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Van Battum, P.; Schaper, N.; Prompers, L.; Apelqvist, J.; Jude, E.; Piaggesi, A.; Bakker, K.; Edmonds, M.; Holstein, P.; Jirkovska, A.; et al. Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation. Diabetes Med. 2011, 28, 199–205. [Google Scholar] [CrossRef] [PubMed]
- Carinci, F.; Uccioli, L.; Massi Benedetti, M.M.; Klazinga, N.S. An in-depth assessment of diabetes-related lower extremity amputation rates 2000–2013 delivered by twenty-one countries for the data collection 2015 of the Organization for Economic Cooperation and Development (OECD). Acta Diabetol. 2020, 57, 347–357. [Google Scholar] [CrossRef] [PubMed]
- Moxey, P.W.; Gogalniceanu, P.; Hinchliffe, R.J.; Loftus, I.M.; Jones, K.J.; Thompson, M.M.; Holt, P.J. Lower extremity amputations—A review of global variability in incidence. Diabetes Med. 2011, 28, 1144–1153. [Google Scholar] [CrossRef]
- Boulton, A.J.; Vileikyte, L.; Ragnarson-Tennvall, G.; Apelqvist, J. The global burden of diabetic foot disease. Lancet 2005, 366, 1719–1724. [Google Scholar] [CrossRef]
- Brasil. Plano de Ações Estratégicas para o Enfrentamento das Doenças Crônicas não Transmissíveis (DCNT) no Brasil 2011-2022 / Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Análise de Situação de Saúde. – Brasília: Ministério da Saúde, 2011. 160 p.: Il. – (Série B. Textos Básicos de Saúde). Available online: https://bvsms.saude.gov.br/bvs/publicacoes/plano_acoes_enfrent_dcnt_2011.pdf (accessed on 28 January 2019).
- Rezende, K.F.; Ferraz, M.B.; Malerbi, D.A.; Melo, N.H.; Nunes, M.P.; Pedrosa, H.C.; Chacra, A.R. Predicted annual costs for in patients with diabetes and foot ulcers in a developing country—A simulation of the current situation in Brazil. Diabetes Med. 2010, 27, 109–112. [Google Scholar] [CrossRef]
- Spichler, E.R.S.; Spichler, D.; Lessa, I.; Forti, A.C.; Franco, L.J.; LaPorte, R.E. Capture-recapture method to estimate lower extremity amputation rates in Rio de Janeiro, Brazil. Rev. Panam Salud Publica 2001, 10, 334–340. [Google Scholar] [CrossRef] [Green Version]
- Lacle, A.; Valero-Juan, L.F. Diabetes-Related Lower-Extremity Amputation Incidence and Risk Factors: A Prospective Seven-Year Study in Costa Rica. Rev. Panam Salud Publica 2012, 32, 192–198. [Google Scholar] [CrossRef] [Green Version]
- Gamba, M.A.; Gotlieb, S.L.D.; Bergamaschi, D.P.; Vianna, L.A.C. Amputações de Extremidades Inferiores por Diabetes Mellitus: Estudo Caso-Controle. Rev. Saúde Pública 2004, 38, 399–404. [Google Scholar] [CrossRef] [Green Version]
- Margolis, D.J.; Hoffstad, O.; Nafash, J.; Leonard, C.E.; Freeman, C.P.; Hennessy, S.; Wiebe, D.J. Location, location, location: Geographic clustering of lower-extremity amputation among Medicare beneficiaries with diabetes. Diabetes Care 2011, 34, 2363–2367. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Edwards, J.L.; Vincent, A.M.; Cheng, H.T.; Feldman, E.L. Diabetic neuropathy: Mechanisms to management. Pharmacol. Ther. 2008, 120, 1–34. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Boulton, A.J. Diabetic neuropathy: Classification, measurement and treatment. Curr. Opin. Endocrinol. Diabetes Obes. 2007, 14, 141–145. [Google Scholar] [CrossRef]
- Reiber, G.E.; Vileikyte, L.; Boyko, E.D.; Del Aguila, M.; Smith, D.G.; Lavery, L.A.; Boulton, A.J. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999, 22, 157–162. [Google Scholar] [CrossRef]
- World Health Organization. Global Report on Diabetes, Geneva, 2016; World Health Organization: Ermita, Manila, Philippines, 2016. Available online: http://www.who.int/mediacentre/factsheets/fs312/en/ (accessed on 16 December 2018).
- Oliveira, S.L.C.; Lunardi Filho, W.D. AIDS e Diabetes Mellitus versus justica distributiva no sistema público de saúde. Rev. Bras. Enferm. 2004, 57, 750–753. [Google Scholar] [CrossRef] [Green Version]
- Anichini, R.; Brocco, E.; Caravaggi, C.M.; Da Ros, R.; Giurato, L.; Izzo, V.; Meloni, M.; Uccioli, L. Physician experts in diabetes are natural team leaders for managing diabetic patients with foot complications. A position statement from the Italian diabetic foot study group. Nutr. Metab. Cardiovasc. Dis. 2020, 30, 167–178. [Google Scholar] [CrossRef]
- Zangirolami-Raimundo, J.; Echeimberg, J.O.; Leone, C. Research methodology topics: Cross-sectional studies. J. Hum. Growth Dev. 2018, 28, 356–360. [Google Scholar] [CrossRef] [Green Version]
- Brasil. Ministério da Saúde. Department of Informatics of the National Health System – DATASUS. System of Registration and Follow-up of Hypertension and Diabetes – SisHiperdia. Available online: http://tabnet.datasus.gov.br/cgi/deftohtm.exe?hiperdia/cnv/hdes.def (accessed on 3 February 2019).
- Brasil. Ministério da Saúde. Portaria Nº 235 de 20 de fevereiro de 2001. Available online: http://bvsms.saude.gov.br/bvs/saudelegis/gm/2001/prt0235_20_02_2001.html (accessed on 3 February 2019).
- Brasil. Ministério da Saúde. Portaria Nº 371 de 04 de março de 2002. Available online: http://bvsms.saude.gov.br/bvs/saudelegis/gm/2002/prt0371_04_03_2002_rep.html (accessed on 3 February 2019).
- Al Sayah, F.; Soprovich, A.; Qiu, W.; Edwards, A.L.; Johnson, J.A. Diabetic foot disease, self-care and clinical monitoring in adults with type 2 diabetes: The Alberta’s Caring for Diabetes (ABCD) cohort study. Can. J. Diabetes 2015, 39, S120–S126. [Google Scholar] [CrossRef]
- Vamos, E.P.; Bottle, A.; Majeed, A.; Millett, C. Trends in lower extremity amputations in people with and without diabetes in England, 1996–2005. Diabetes Res. Clin. Pract. 2010, 87, 275–282. [Google Scholar] [CrossRef]
- Lombardo, F.L.; Maggini, M.; De Bellis, A.; Seghieri, G.; Anichini, R. Lower extremity amputations in persons with and without diabetes in Italy, 2001–2010. PLoS ONE 2014, 9, 1–7. [Google Scholar] [CrossRef] [Green Version]
- Rathsman, B.; Jensen-Urstad, K.; Nyström, T. Intensified insulin treatment is associated with improvement in skin microcirculation and ischemic foot ulcer in patients with type 1 diabetes mellitus: A long-term follow-up study. Diabetologia 2014, 57, 1703–1710. [Google Scholar] [CrossRef]
- Adler, A.I.; Stratton, I.M.; Neil, H.A.W.; Yudkin, J.S.; Matthews, D.R.; Cull, C.A.; Holman, R.R. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study. BMJ 2000, 321, 412–419. [Google Scholar] [CrossRef] [Green Version]
- Costa, R.H.R.; Cardoso, N.A.; Procópio, R.J.; Navarro, T.P.; Dardik, A.; Cisneros, L.L. Diabetic foot ulcer carries high amputation and mortality rates, particularly in the presence of advanced age, peripheral artery disease and anemia. Diabetes Metab. Syndr. Clin. Res. Rev. 2017, 11, S583–S587. [Google Scholar] [CrossRef]
- Felício, J.S.; Koury, C.C.; Zahalan, N.A.; Resende, F.S.; Lemos, M.N.; Pinto, R.J.M.C.; Souza Neto, N.J.K.; Franco, I.I.F.; Oliveira, M.C.N.I.; Alcântara, A.L.; et al. Ankle-brachial index and peripheral arterial disease: An evaluation including a type 2 diabetes mellitus drug-naïve patients cohort. Diabetes Vasc. Dis. Res. 2019, 16, 344–350. [Google Scholar] [CrossRef] [Green Version]
- Prompers, L.; Huijberts, M.; Apelqvist, J.; Jude, E.; Piaggesi, A.; Bakker, K.; Tennvall, G.R. Delivery of care to diabetic patients with foot ulcers in daily practice: Results of the Eurodiale Study, a prospective cohort study. Diabetes Med. 2008, 25, 700–707. [Google Scholar] [CrossRef]
- Silva, L.R.; Fernandes, G.M.; Morales, N.U.; Sobreira, M.L.; Moura, R.; Bertanha, M.; Yoshida, W.B. Results of One-Stage or Staged Amputations of Lower Limbs Consequent to Critical Limb Ischemia and Infection. Ann. Vasc. Surg. 2017, 46, 218–225. [Google Scholar] [CrossRef] [Green Version]
- Santos, K.P.B.D.; Luz, S.C.T.D.; Mochizuki, L.; D’orsi, E. Burden of disease from lower limb amputations attributable to diabetes mellitus in Santa Catarina State, Brazil, 2008–2013. Cad. Saúde Publica 2018, 34, 1–13. [Google Scholar] [CrossRef] [Green Version]
- Monteiro-Soares, M.; Boyko, E.J.; Ribeiro, J.; Ribeiro, I.; Dinis-Ribeiro, M. Predictive factors for diabetic foot ulceration: A systematic review. Diabetes/Metab. Res. Rev. 2012, 28, 574–600. [Google Scholar] [CrossRef]
- Tang, Z.Q.; Chen, H.L.; Zhao, F.F. Gender differences of lower extremity amputation risk in patients with diabetic foot: A meta-analysis. Int. J Lower Extrem. Wounds 2014, 13, 197–204. [Google Scholar] [CrossRef]
- Seghieri, G.; Policardo, L.; Gualdani, E.; Anichini, R.; Francesconi, P. Gender difference in the risk for cardiovascular events or mortality of patients with diabetic foot syndrome. Acta Diabetol. 2019, 56, 561–567. [Google Scholar] [CrossRef]
- Kautzky-Willer, A.; Harreiter, J.; Pacini, G. Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus. Endocr. Rev. 2016, 37, 278–316. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Seghieri, G.; Policardo, L.; Anichini, R.; Franconi, F.; Campesi, I.; Cherchi, S.; Tonolo, G. The Effect of Sex and Gender on Diabetic Complications. Curr. Diabetes Rev. 2017, 13, 148–160. [Google Scholar] [CrossRef]
- Richter, L.; Freisinger, E.; Lüders, F.; Gebauer, K.; Meyborg, M.; Malyar, N.M. Impact of diabetes type on treatment and outcome of patients with peripheral artery disease. Diabetes Vasc. Dis. Res. 2018, 15, 504–510. [Google Scholar] [CrossRef] [PubMed]
- O’Hare, J.A.; Abuaisha, F.; Geoghegan, M. Prevalence and forms of neuropathic morbidity in 800 diabetics. Ir. J. Med. Sci. 1994, 163, 132–135. [Google Scholar] [CrossRef] [PubMed]
- Reindel, J.; Zander, E.; Heinke, P.; Kohnert, K.D.; Allwardt, C.; Kerner, W. Metabolisches syndrom bei patienten mit diabetes mellitus typ 1. Herz 2004, 29, 463–469. [Google Scholar] [CrossRef] [PubMed]
- Al-Rubeaan, K.; Al Derwish, M.; Ouizi, S.; Youssef, A.M.; Subhani, S.N.; Ibrahim, H.M.; Alamri, B.N. Diabetic foot complications and their risk factors from a large retrospective cohort study. PLoS ONE 2015, 10, 1–17. [Google Scholar] [CrossRef]
- Lai, Y.J.; Hu, H.Y.; Lin, C.H.; Lee, S.T.; Kuo, S.C.; Chou, P. Incidence and risk factors of lower extremity amputations in people with type 2 diabetes in Taiwan, 2001–2010. J. Diabetes 2015, 7, 260–267. [Google Scholar] [CrossRef]
- Sarfo-Kantanka, O.; Sarfo, F.S.; Kyei, I.; Agyemang, C.; Mbanya, J.C. Incidence and determinants of diabetes-related lower limb amputations in Ghana, 2010–2015-a retrospective cohort study. BMC Endocr. Disord. 2019, 19, 1–8. [Google Scholar] [CrossRef] [Green Version]
- Parisi, M.C.R.; Neto, A.M.; Menezes, F.H.; Gomes, M.B.; Teixeira, R.M.; De Oliveira, J.E.P.; de Oliveira, A.M.A. Baseline characteristics and risk factors for ulcer, amputation and severe neuropathy in diabetic foot at risk: The BRAZUPA study. Diabetol. Metab. Syndr. 2016, 8, 25. [Google Scholar] [CrossRef] [Green Version]
- Nakanishi, N.; Nakamura, K.; Matsuo, Y.; Suzuki, K.; Tatara, K. Cigarette smoking and risk for impaired fasting glucose and type 2 diabetes in middle-aged Japanese men. Ann. Int. Med. 2000, 133, 183–191. [Google Scholar] [CrossRef]
- Clair, C.; Rigotti, N.A.; Meigs, J.B. Smoking cessation, weight change, and risk of cardiovascular disease-reply. JAMA 2013, 310, 323. [Google Scholar] [CrossRef]
- Jang, J.J.; Bhapkar, M.; Coles, A.; Vemulapalli, S.; Fordyce, C.B.; Lee, K.L.; Udelson, J.E.; Hoffmann, U.; Tardif, J.C.; Jones, W.S.; et al. Predictive Model for High-Risk Coronary Artery Disease. Circ. Cardiovasc. Imaging 2019, 12, 1–17. [Google Scholar] [CrossRef] [Green Version]
- Mutie, P.M.; Giordano, G.N.; Franks, P.W. Lifestyle precision medicine: The next generation in type 2 diabetes prevention? BMC Med. 2017, 15, 171. [Google Scholar] [CrossRef]
- Matsushita, K.; Ballew, S.H.; Coresh, J.; Arima, H.; Ärnlöv, J.; Cirillo, M.; Ebert, N.; Hiramoto, J.S.; Kimm, H.; Shlipak, M.G.; et al. Measures of chronic kidney disease and risk of incident peripheral artery disease: A collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2017, 5, 718–728. [Google Scholar] [CrossRef] [Green Version]
- Criqui, M.H.; Aboyans, V. Epidemiology of peripheral artery disease. Circ. Res. 2015, 116, 1509–1526. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Garimella, P.S.; Hirsch, A.T. Peripheral artery disease and chronic kidney disease: Clinical synergy to improve outcomes. Adv. Chronic Kidney Dis. 2014, 21, 460–471. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Vinuesa, S.G.; Ortega, M.; Martinez, P.; Goicoechea, M.; Campdera, F.G.; Luño, J. Subclinical peripheral arterial disease in patients with chronic kidney disease: Prevalence and related risk factors. Kidney Int. 2005, 67, 44–47. [Google Scholar] [CrossRef] [Green Version]
- Margolis, D.J.; Hofstad, O.; Feldman, H.I. Association between renal failure and foot ulcer or lower-extremity amputation in patients with diabetes. Diabetes Care 2008, 31, 1331–1336. [Google Scholar] [CrossRef] [Green Version]
- Fowkes, F.G.; Murray, G.D.; Butcher, I.; Heald, C.L.; Lee, R.J.; Chambless, L.E.; Folsom, A.R.; Hirsch, A.T.; Dramaix, M.; DeBacker, G.; et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: A meta-analysis. JAMA 2008, 300, 197–208. [Google Scholar] [CrossRef] [Green Version]
- Chen, S.C.; Chang, J.M.; Liu, W.C.; Tsai, Y.C.; Tsai, J.C.; Hsu, P.C.; Lin, T.H.; Lin, M.Y.; Su, H.M.; Hwang, S.J.; et al. Brachial-ankle pulse wave velocity and rate of renal function decline and mortality in chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2011, 6, 724–732. [Google Scholar] [CrossRef] [Green Version]
- Jiang, Y.; Ran, X.; Jia, L.; Yang, C.; Wang, P.; Ma, J.; Yin, H. Epidemiology of type 2 diabetic foot problems and predictive factors for amputation in China. Int. J. Lower Extrem. Wounds 2015, 14, 19–27. [Google Scholar] [CrossRef] [PubMed]
- American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes—2018. Diabetes Care 2018, 41, S13–S27. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Boulton, A.; Armstrong, D.; Albert, S.; Frykberg, R.; Hellman, R.; Kirkman, M.; Sheehan, P. Comprehensive foot examination and risk assessment. Endocr. Pract. 2008, 14, 576–583. [Google Scholar] [CrossRef] [PubMed]
- Rodrigues, J.; Mitta, N. Diabetic foot and gangrene. Gangrene-Current Concepts and Management Options. Alexander Vitin, ed. InTech. Available online: https://www.intechopen.com/books/gangrene-current-concepts-and-management-options/diabetic-foot-and-gangrene. (accessed on 9 June 2020).
- Leone, S.; Pascale, R.; Vitale, M.; Esposito, S. Epidemiology of diabetic foot. Infez. Med. 2012, 20, 8–13. [Google Scholar] [PubMed]
- Nascimento, M.M.; Pereira, L.G.D.; Cordeiro, P.R.N.; Araújo, L.M.G. Comparison and agreement of criteria for the BMI classification of physically active elderly women living in the Backlands, semi-arid Region. J. Hum. Growth Dev. 2017, 27, 342–349. [Google Scholar] [CrossRef] [Green Version]
- Pires, M.R.; Bani, R.C.F.; Lima, G.Z.; Haddad, M.I.R.; Takamoto, P.M.; Pires, L.A.R.; Manganaro, M.M.; Croscioli, M.R.F.B.; Fernani, D.C.G.L.; Vanderlei, L.C.M.; et al. Problems with adherence to treatment among adolecents with diabetes mellitus type 1. J. Hum. Growth Dev. 2016, 26, 21–27. [Google Scholar] [CrossRef] [Green Version]
- Abreu, L.C.; Pereira, V.X.; Silva, R.P.M.; Junior, H.M.; Bezerra, I.M.P. The right to scientific information: One of the main elements of the unified health system. J. Hum. Growth Dev. 2017, 27, 258–261. [Google Scholar] [CrossRef] [Green Version]
- Dircinha, S. Scientific method and research in health: Orientation for professional practice. J. Hum. Growth Dev. 2019, 29, 5–9. [Google Scholar] [CrossRef] [Green Version]
Variables | Total | % | Type I DM | % | Type II DM | % | DM with Hypertension | % |
---|---|---|---|---|---|---|---|---|
Sample | 64,196 | 100 | 2512 | 3.9 | 6995 | 10.9 | 54,689 | 85.2 |
Gender | ||||||||
Male | 21,416 | 33.4 | 1138 | 45.3 | 2875 | 41.1 | 17,403 | 31.8 |
Female | 42,780 | 66.6 | 1374 | 54.7 | 4120 | 58.9 | 37,286 | 68.2 |
Age group | ||||||||
Up to 19 | 696 | 1.1 | 391 | 15.6 | 99 | 1.4 | 206 | 0.4 |
20 to 39 | 5219 | 8.1 | 672 | 26.8 | 995 | 14.2 | 3552 | 6.5 |
40 to 59 | 29,282 | 45.6 | 922 | 36.7 | 3,767 | 53.9 | 24,593 | 45.0 |
60 of age or older | 28,999 | 45.2 | 527 | 21.0 | 2,134 | 30.5 | 26,338 | 48.2 |
Variables | Yes n (P%) 95% CI | No n (P%) 95% CI | PR (95%CI) | “p” |
---|---|---|---|---|
Amputation | 29 (1.2) 0.8–1.7 | 2483 (98.8) 98.3–99.2 | ||
Gender | ||||
Male | 21 (1.8) 1.2–2.9 | 1117 (98.2) 97.1–98.8 | 3.17 (1.41–7.13) | 0.0057 |
Female | 8 (0.6) 0.3–1.2 | 1366 (99.4) 98.8–99.7 | ||
Age group | ||||
Up to 29 | 6 (0.8) 0.3–1.9 | 701 (99.2) 98.1–99.7 | 1.79 (0.62–5.12) | 0.5505 |
30 to 59 | 15 (1.2) 0.7–2 | 1263 (98.8) 98.0–99.3 | 1.29 (0.55–3.03) | |
60 and + | 8 (1.5) 0.7–3.1 | 519 (98.5) 96.9–99.3 | ||
Risk factors and comorbidities | ||||
Smoking | ||||
Yes | 9 (2.6) 1.3–5 | 340 (97.4) 95–98.7 | 2.79 (1.28–6.08) | 0.0158 |
No | 20 (0.9) 0.6–1.5 | 2143 (99.1) 98.5–99.4 | ||
Sedentary lifestyle | ||||
Yes | 14 (1.5) 0.8–2.6 | 926 (98.5) 97.4–99,2 | 1.56 (0.76–3.22) | 0.3067 |
No | 15 (1) 0.6–1.6 | 1557 (99) 98.4–99.4 | ||
Overweight | ||||
Yes | 6 (1.1) 0.5–2.5 | 532 (98.9) 97.5–99.5 | 0.96 (0.39–2.34) | 0.8953 |
No | 23 (1.2) 0.8–1.8 | 1951 (98.8) 98.2–99.2 | ||
AMI | ||||
Yes | 4 (6.1) 2–15.6 | 62 (93.9) 84.4–98 | 5.93 (2.12–16.56) | 0.0014 |
No | 25 (1) 0.7–1.5 | 2421 (99) 98.5–99.3 | ||
Stroke | ||||
Yes | 3 (4.8) 1.3–14.4 | 59 (95.2) 85.6–98.7 | 4.56 (1.42–14.66) | 0.0317 |
No | 26 (1.1) 0.7–1.6 | 2424 (98.9) 98.4–99.3 | ||
CKD | ||||
Yes | 8 (7.2) 3.4–14.1 | 103 (92.8) 85.9–96.6 | 8.24 (3.73–18.19) | <0.0001 |
No | 21 (0.9) 0.6–1.4 | 2380 (99.1) 98.6–99.4 | ||
DF | ||||
Yes | 17 (23) 14.3–34.5 | 57 (77) 65.5–85.7 | 46.67 (23.13–94.16) | <0.0001 |
No | 12 (0.5) 0.3–0.9 | 2426 (99.5) 99.1–99.7 |
Variables | Yes n (P%) 95% CI | No n (P%) 95% CI | PR (95% CI) | “p” |
---|---|---|---|---|
Amputation | 104 (1.5) 1.2–1.8 | 6891 (98.5) 98.2–98.8 | ||
Gender | ||||
Male | 66 (2.3) 1.8–2.9 | 2809 (97.7) 97.1–98.2 | 2.49 (1.67–3.7) | <0.0001 |
Female | 38 (0.9) 0.7–1.3 | 4082 (99.1) 98.7–99.3 | ||
Age group | ||||
Up to 29 | 3 (0.9) 0.2–2.9 | 321 (99.1) 97.1–99.8 | 2.33 (0.73–7.44) | 0.0084 |
30 to 59 | 55 (1.2) 0.9–1.6 | 4482 (98.8) 98.4–99.1 | 1.78 (1.21–2.62) | |
60 and + | 46 (2.2) 1.6–2.9 | 2088 (97.8) 97.1–98.4 | ||
Risk factors and comorbidities | ||||
Smoking | ||||
Yes | 26 (2.3) 1.5–3.4 | 1097 (97.7) 96.6–98.5 | 1.74 (1.12–2.7) | 0.0178 |
No | 78 (1.3) 1.1–1.7 | 5794 (98.7) 98.3–98.9 | ||
Sedentary lifestyle | ||||
Yes | 64 (1.9) 1.5–2.4 | 3338 (98.1) 97.6–98.5 | 1.69 (1.14–2.5) | 0.0107 |
No | 40 (1.1) 0.8–1.5 | 3553 (98.9) 98.5–99.2 | ||
Overweight | ||||
Yes | 33 (1.2) 0.8–1.7 | 2690 (98.8) 98.3–99.2 | 0.73 (0.48–1.1) | 0.1570 |
No | 71 (1.7) 1.3–2.1 | 4201 (98.3) 97.9–98.7 | ||
AMI | ||||
Yes | 18 (11.6) 7.2–18 | 137 (88.4) 82–92.8 | 9.24 (5.7–14.96) | <0.0001 |
No | 86 (1.3) 1–1.6 | 6754 (98.7) 98.4–99 | ||
Stroke | ||||
Yes | 17 (11.2) 6.8-17.6 | 135 (88.8) 82.4-93.2 | 8.8 (5.37-14.42) | <0.0001 |
No | 87 (1.3) 1-1.6 | 6,756 (98.7) 98.4-99 | ||
CKD | ||||
Yes | 20 (6.8) 4.3–10.5 | 272 (93.2) 89.5–95.7 | 5.47 (3.4–8.77) | <0.0001 |
No | 84 (1.3) 1–1.6 | 6619 (98.7) 98.4–99 | ||
DF | ||||
Yes | 71 (31.1) 25.3–37.6 | 157 (68.9) 62.4–74.7 | 63.86 (43.18–94.44) | <0.0001 |
No | 33 (0.5) 0.3–0.9 | 6734 (99.5) 99.1–99.7 |
Variables | Yes n (P%) 95% CI | No n (P%) 95% CI | PR (95% CI) | “p” |
---|---|---|---|---|
Amputation | 1224 (2.2) 2.1–2.4 | 53,465 (97.8) 97.6–97.9 | ||
Gender | ||||
Male | 492 (2.8) 2.6-3.1 | 16,911 (97.2) 96.9–97.4 | 1.44 (1.29-1.61) | <0.0001 |
Female | 732 (2) 1.8-2.1 | 36,554 (98) 97.9–98.2 | ||
Age Group | ||||
Up to 29 | 23 (2.5) 1.6–3.7 | 908 (97.5) 96.3–98.4 | 0.0540 | |
30 to 59 | 572 (2.1) 1.9–2.3 | 26,848 (97.9) 97.7–98.1 | 1.18 (0.78–1.79) | |
60 and + | 629 (2.4) 2.2–2.6 | 25,709 (97.6) 97.4–97.8 | 1.03 (0.69–1.56) | |
Risk factors and comorbidities | ||||
Smoking | ||||
Yes | 392 (4.4) 4–4.9 | 8434 (95.6) 95.1–96 | 2.45 (2.18–2.75) | <0.0001 |
No | 832 (1.8) 1.7–1.9 | 45,031 (98.2) 98.1–98.3 | ||
Sedentary lifestyle | ||||
Yes | 686 (2.4) 2.3–2.6 | 27,464 (97.6) 97.4–97.7 | 1.20 (1.08–1.34) | 0.0013 |
No | 538 (2) 1.9–2.2 | 26,001 (98) 97.8–98.1 | ||
Overweight | ||||
Yes | 565 (2) 1.9–2.2 | 27,271 (98) 97.8–98.1 | 0.83 (0.74–0.92) | 0.0009 |
No | 659 (2.5) 2.3–2.6 | 26,194 (97.5) 97.4–97.7 | ||
AMI | ||||
Yes | 369 (6.8) 6.1–7.5 | 5,078 (93.2) 92.5–93.9 | 3.9 (3.46–4.39) | <0.0001 |
No | 855 (1.7) 1.6–1.9 | 48,387 (98.3) 98.1–98.4 | ||
Stroke | ||||
Yes | 362 (6.8) 6.2–7.5 | 4,951 (93.2) 92.5–93.8 | 3.9 (3.46–4.4) | <0.0001 |
No | 862 (1.7) 1.6–1.9 | 48,514 (98.3) 98.1–98.4 | ||
CKD | ||||
Yes | 396 (8.5) 7.7–9.4 | 4250 (91.5) 90.6–92.3 | 5.15 (4.59–5.78) | <0.0001 |
No | 828 (1.7) 1.5–1.8 | 49,215 (98.3) 98.2–98.5 | ||
DF | ||||
Yes | 726 (29.3) 27.5–31.1 | 1754 (70.7) 68.9–72.5 | 30.69 (27.58–34.15) | <0.0001 |
No | 498 (1) 0.9–1 | 51,711 (99) 99–99.1 |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Costa, W.J.T.; Penha-Silva, N.; Bezerra, I.M.P.; Paulo dos Santos, I.; Ramos, J.L.S.; Castro, J.M.d.; Pereira, J.E.G.; Silva, A.P.d.; Monteiro, A.; de Abreu, L.C. Analysis of Diabetes Mellitus-Related Amputations in the State of Espírito Santo, Brazil. Medicina 2020, 56, 287. https://doi.org/10.3390/medicina56060287
Costa WJT, Penha-Silva N, Bezerra IMP, Paulo dos Santos I, Ramos JLS, Castro JMd, Pereira JEG, Silva APd, Monteiro A, de Abreu LC. Analysis of Diabetes Mellitus-Related Amputations in the State of Espírito Santo, Brazil. Medicina. 2020; 56(6):287. https://doi.org/10.3390/medicina56060287
Chicago/Turabian StyleCosta, Wendel Jose Teixeira, Nilson Penha-Silva, Italla Maria Pinheiro Bezerra, Ismar Paulo dos Santos, José Lucas Souza Ramos, Jonathan Mendes de Castro, Júlio Eduardo Gomes Pereira, Alan Patrício da Silva, Adilson Monteiro, and Luiz Carlos de Abreu. 2020. "Analysis of Diabetes Mellitus-Related Amputations in the State of Espírito Santo, Brazil" Medicina 56, no. 6: 287. https://doi.org/10.3390/medicina56060287
APA StyleCosta, W. J. T., Penha-Silva, N., Bezerra, I. M. P., Paulo dos Santos, I., Ramos, J. L. S., Castro, J. M. d., Pereira, J. E. G., Silva, A. P. d., Monteiro, A., & de Abreu, L. C. (2020). Analysis of Diabetes Mellitus-Related Amputations in the State of Espírito Santo, Brazil. Medicina, 56(6), 287. https://doi.org/10.3390/medicina56060287